New approach to phospholipidosis prediction
Ended Cooperative Agreement Awarded Last action
- Award ID
- R44FD004052
- Recipient
-
Echelon Biosciences Inc. UEI EDK8FFD24SC4
- Awarding agency
-
FDA Office of Acquisition and Grant Services
Food and Drug Administration, Department of Health and Human Services
- Obligated
- $862,769
Award facts
- Assistance listing
- 93.103 Food and Drug Administration Research
- Completion date
- Originally
- Funding agency
- Center for Drug Evaluation and Research Food and Drug Administration, Department of Health and Human Services
- Place of performance
- Emigration Canyon, UT 84108, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | -$12,811 | |
| Amendment | $0 | |
| Amendment | $426,154 | |
| Original award | $449,426 |
Quick answers
Who received award R44FD004052?
R44FD004052 was awarded to Echelon Biosciences Inc. by FDA Office of Acquisition and Grant Services (Food and Drug Administration) on September 1, 2011.
How much is award R44FD004052 worth?
$862,769 has been obligated on R44FD004052.
Which agency awarded R44FD004052?
FDA Office of Acquisition and Grant Services (Food and Drug Administration) awarded R44FD004052, with funding from Center for Drug Evaluation and Research (Food and Drug Administration).
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award